Schedule 13D ownership disclosure
BELLICUM PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 079481404
Event date: 2023-11-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,365,472
- Percent of class
- 19.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-120984
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Nov 24, 2023
- Reporting period
- Nov 21, 2023
- Description
- Schedule 13D beneficial ownership